Afleveringen
-
Look into the future of biotech with hosts James Zanewicz, JD, LLM, RTTP, and Elaine Hamm, PhD, as they recount their experiences and key takeaways from the June 2024 BIO International Convention in San Diego. This year’s conference brought together leaders in the biotech industry to explore groundbreaking advancements and discuss the latest trends shaping the future of biotech. James and Elaine delve into BIO 2024’s major themes, where many conversations focused on either women's health or the transformative role of AI in healthcare. They provide listeners with an insider’s perspective on the most significant areas of innovation, investment and collaborative efforts that promise to propel the industry forward.
Key Highlights:
• Focus on Women’s Health: Discussions on innovative research and emerging technologies addressing women's unique health challenges.
• AI in Healthcare: The rapid adoption of AI enhancing diagnostics, treatment, and patient care.
• Successful Side Events: Highlights from highly successful side events like the Bullpen, Ticket to Biotech, and Bio from the Bayou.
• Investment: Last year most investors focused on their current portfolio but new investments are picking back up. However, with the IPO market still sluggish many investors were looking for an end game of acquisitions or exit plans.
• Productive Partnering: Reflections on the productive partnering sessions and the optimistic outlook for the future of the biotech industry.
Your support propels our podcast; please like, share, and subscribe to BIO from the BAYOU. When you engage it enables us to produce more compelling content and reach a wider listener base passionate about biotech breakthroughs.
-
In this engaging episode of BIO from the BAYOU, host James Zanewicz, JD, LLM, RTTP, sits down with Marc Malandro, PhD, to explore the impactful work of the Chan Zuckerberg Initiative (CZI). Founded in 2015, CZI initially broadly aims to tackle some of society's most pressing challenges to create a more inclusive, just, and healthy future. Having announced a next-phase on being a science-forward organization in January of 2024, Malandro is an increasingly key figure in CZI’s ongoing initiatives (at the time of the interview as VP of Science Operations and now serving as Chief Operating Officer for the entire organization).
Malandro also delves into the BioHub Network, which empowers scientists to pursue bold, high-risk ideas, and emphasizes the crucial role of collaboration in driving scientific progress. This episode was recorded at Bio on the Bayou, an annual event in New Orleans that highlights academic science, biotech innovations, and startups from the Gulf South region.
-
Zijn er afleveringen die ontbreken?
-
Join us for a deep dive into the fascinating world of sex differences in health with Dr. Heddwen Brooks, Professor and Chair of Physiology at the Tulane School of Medicine. Host James Zanewicz engages Dr. Brooks in a compelling discussion about her extensive research on sex differences in physiology, with a particular focus on women’s health during various stages of menopause and aging. Additionally, Dr. Brooks sheds light on the significant impact of these differences on COVID-19 outcomes.
Tune in for an enlightening discussion on these critical aspects of physiology and health disparities.
-
Delve into the groundbreaking world of novel vaccine adjuvants with guests Lisa Morici, PhD, Professor of Microbiology, and James McLachlan, PhD, Associate Professor of Immunology, who’s labs collaborate at the Tulane University School of Medicine. This episode spotlights their innovative vaccine adjuvant, T-Vant, detailing its conception, evolution, and why it holds a transformative edge over existing adjuvants. (And yes, vaccine companies – it IS available to license and partner!)
Discussion extends to the current vaccine landscape, exploring shifts, trends, and the critical role of advanced adjuvants like T-Vant. Guiding us through this informative journey is our frequent (and popular) host, Elaine Hamm, PhD.
-
The tables turn as frequent host James Zanewicz, JD, LLM, RTTP, steps into the guest seat to discuss his position as Chief Strategy Officer at the Tulane University School of Medicine and Tulane National Primate Research Center. James shares the comprehensive strategies he has put in place at Tulane, including: fostering continuous dialogues with biotech companies and investors, positioning scientists and clinicians as key opinion leaders, and collaborating closely with startups to offer them services and access to Tulane’s expansive network. Guest host Allyson Best, MBA, also contributes her unique insights, making this a must-listen episode of BIO from the BAYOU.
Enjoyed the episode? Support us by liking, sharing, and subscribing to BIO from the BAYOU. Your engagement helps us bring more exciting content your way and reach more listeners passionate about the biotech industry.
-
Idiopathic Pulmonary Fibrosis (IPF) is a devastating lung disease affecting millions worldwide, with a grim prognosis of only three to five years post-diagnosis. In this episode, leading lung disease expert Victor Thannickal, MD, delves into the symptoms, progression, and impacts of IPF. He also sheds light on promising new drug therapies emerging from his lab, offering hope in the fight against this relentless disease. Host Elaine Hamm, PhD, skillfully navigates the complex landscape of IPF, making this a must-listen for anyone interested in cutting-edge biotech developments.
If you enjoyed the episode, please consider liking, sharing, and subscribing to BIO from the BAYOU. Your support helps us continue delivering high-quality content to listeners passionate about the biotech industry.
-
Are you interested in learning about neurotechnology and innovation? Then this episode is for you! Join JoJo Platt, a founder and executive faculty for the Cleveland NeuroDesign Entrepreneurs Workshop, as she breaks down the goals, agenda, and value of this intensive weekend-long course. This episode is hosted James Zanewicz, JD, LLM, RTTP, who will also be returning as faculty for the 2024 program.
If you’re passionate about neurotechnology and entrepreneurial innovation, this episode is a must-listen! Additionally, keep an eye out for details on the upcoming AI & Healthcare Design Workshop.
Enjoyed the episode? Support us by liking, sharing, and subscribing to BIO from the BAYOU. Your engagement helps us bring more exciting content your way and reach more listeners passionate about the biotech industry.
-
In this compelling episode of BIO from the BAYOU, we explore groundbreaking developments in the field of pain management with James Zadina, PhD, a leading expert from Tulane University. Amidst the pressing opioid crisis, Zadina introduces us to “Tuleva”—a revolutionary peptide that promises to change the way we address chronic pain, sidestepping the notorious side effects associated with traditional opioids.
Hosted by Elaine Hamm, PhD, this episode doesn't only shine a light on Tuleva's scientific significance but also opens up discussions about the potential of collaboration in furthering this research. Zadina walks us through the intricate mechanisms of how Tuleva works and the hopeful path it paves for those suffering from chronic pain.
-
In this enlightening episode, we welcome back Kalen Hall, PhD, and Leo Williams, PhD, the dynamic duo from the startup Informuta. They join our new host, Nick Pashos, PhD, to peel back the layers on what it's like to compete in the high-stakes arena of pitch competitions, with a special focus on their experiences at the Rice Business Plan Competition.
Whether you're part of a startup considering the leap into the competitive landscape of business plan competitions or an investor keen on discovering groundbreaking ventures like Informuta, this episode is packed with valuable insights.
Enjoyed the episode? Support us by liking, sharing, and subscribing to BIO from the BAYOU. Your engagement helps us bring more exciting content your way and reach more listeners passionate about the biotech industry.
-
Bill Wimley, PhD, a renowned expert in biochemistry and molecular biology, guests in a must-listen episode for anyone excited about the intersection of biotechnology and healthcare. Wimley's work represents a significant advancement in the fight against drug-resistant infections, offering not just hope but real, tangible solutions.. This episode, spearheaded by Elaine Hamm, PhD , dives into the fascinating world of antimicrobial peptides, with a specific focus on Wimley’s engineered peptide, D-CONGA.
Enjoyed the episode? Support us by liking, sharing, and subscribing to BIO from the BAYOU. Your engagement helps us bring more exciting content your way and reach more listeners passionate about the biotech industry.
-
Explore the avian flu's impact on the US dairy and cattle industry with Chad Roy, PhD, a renowned expert in microbiology and immunology from the Tulane School of Medicine. Learn about the safety of our dairy products, the flu's transmission risks, and our preparedness for potential outbreaks. Hosted by Sharon Courtney (who conveyed an incredible amount of information to the public throughout the COVID outbreak), this episode illuminates the complex interplay between public health and infectious diseases through her expert questions and an insightful discussion.
Ideal for both the general public and those interested in public health and science, Episode 31 equips listeners with timely and crucial knowledge on avian influenza. Tune in to gain expert insights into this pressing issue.
-
You’ve heard Elaine Hamm, PhD, discuss her role as Executive in Residence at Tulane School of Medicine and Executive Director of the Alliance for Artificial Intelligence in Healthcare, but did you know that she does much more? Elaine discusses her various startup companies, including Ascend BioVentures, Cadenza Bio, CLAIRIgene, Otologic Pharmaceutics, and even a wine bar called The Study. She also gives advice on how to juggle so many different projects effectively. Episode hosted by James Zanewicz, JD, LLM, RTTP.
-
Startup entrepreneurs coming from academic universities face countless challenges, many of which revolve around the fear of failure. Nick Pashos, PhD, Tulane School of Medicine’s Entrepreneur in Residence, discusses the common obstacles academic (and other) start-up companies face, and how he can provide support in his new role. He pulls from his own experiences as a startup CEO/Founder and talks about several of the emerging Tulane Medicine startups he is excited about. Episode hosted by Elaine Hamm, PhD.
-
“Innovation ecosystem” is a term often used in biotech, but what actually goes into building a strong ecosystem? Mark Crowell, RTTP, Executive Entrepreneur in Residence at UNC Chapel Hill, talks about the elements that go into developing an innovation ecosystem, pulling from his experiences at Research Triangle Park in North Carolina. He also provides details about his startup company, Arkane Innovation. Episode hosted by Patrick Reed, RTTP. This episode was recorded at Bio on the Bayou, the annual event in New Orleans showcasing academic science, biotech, and startups from the entire Gulf South region.
-
Partnerships in biotech are critical to innovation; however, forming and maintaining partnerships can often be a daunting task. Tari Suprapto, PhD, the Director of Search and Evaluation at Novo Nordisk, provides tips and insights into managing relationships between academic and corporate partners. She highlights the importance of personal connection, common goals, and communication within partnerships, and touches on dealing with imposter syndrome. Episode hosted by Kaneisha Akinpelumi. This episode was recorded at Bio on the Bayou, the annual event in New Orleans showcasing academic science, biotech, and startups from the entire Gulf South region.
-
As the application of artificial intelligence (AI) in the field of healthcare becomes more prevalent, an organization to convene all the relevant stakeholders has emerged. Frequent Host Elaine Hamm, PhD, joins as a podcast guest in her role as Executive Director of the Alliance for Artificial Intelligence in Healthcare (AAIH), the international advocacy organization dedicated to the responsible adoption and application of AI in healthcare. She highlights the many ways AI is currently being used in the healthcare space, the potential it holds, and the importance of data diversity and access in the utilization of AI. She then highlights AAIH’s recent commentaries on both the Unified Patient Record and President Biden’s Executive Order on AI, and how you can become a member of this important organization. Episode hosted by James Zanewicz, JD, LLM, RTTP.
-
Recommended health habits often put the main focus on things like weight loss, dieting, and physical appearance. The notion of “whole health,” however, expands health goals across other aspects of wellbeing such as sleep, stress, and mental optimization to achieve a more complete picture of health. Tiffany Stewart, PhD, discusses the importance of offering patients practical solutions for solving their health challenges and how her lab is leveraging digital health tools to accomplish this. She offers insight into how we can all achieve our health goals through meaningful incremental change. Episode hosted by Patrick Reed, RTTP.
-
Silicon Valley Bank (SVB) has been an important financial resource for startup companies and is now backed by the 125-year-old First Citizens Bank. Pooja Majmudar, PhD, SVB’s Director of Startup Banking, explains her non-linear career path, how she works with startup companies at SVB, and the kinds of services SVB can provide to startups. She also describes the ecosystem of collaborators and strategic partners that SVB has built for entrepreneurs. Episode hosted by Elaine Hamm, PhD. This episode was recorded at Bio on the Bayou, the annual event in New Orleans showcasing academic science, biotech, and startups from the entire Gulf South region.
-
The Equalize Program is a groundbreaking virtual mentor program and pitch competition dedicated to addressing the gender disparities in the founders of academic startups. Co-founder Kirsten Leute, MBA, discusses the program’s history and goals, key building blocks that make it a transformative experience for founders, why Equalize is so essential, and how listeners can get involved. She also shares some of the findings from her research on the barriers women experience in academia. Episode hosted by Sharon Courtney.
-
The Bullpen is a club that gathers life science-based investors and executives with the goal of partnership and collaboration. In this episode, our host, Elaine Hamm, PhD, engages in a captivating conversation with Christiaan Engstrom, MBA, the esteemed Curator of The Bullpen. As they delve into his career journey, including his most recent startup venture, Evia Bio, Christiaan provides a unique perspective on the club's mission and its incredible benefits for members. He highlights how to engage and become a member, and the Bullpen’s upcoming event at the JPMorgan conference in 2024.
- Laat meer zien